Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) BTC-USD
67,896.91 +2,168.31 (+3.30%) CMC Crypto 200
1,375.09 +44.49 (+3.34%)
Churchill Capital Corp VII (CVII)
| Previous close | 10.78 |
| Open | 10.79 |
| Bid | 7.75 x 200 |
| Ask | 13.82 x 200 |
| Day's range | 10.79 - 10.80 |
| 52-week range | 10.36 - 10.85 |
| Volume | |
| Avg. volume | 56,837 |
| Market cap | 987.979M |
| Beta (5Y monthly) | 0.04 |
| PE ratio (TTM) | 1,079.00 |
| EPS (TTM) | 0.01 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireSpecial Meeting of Churchill VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment to be Adjourned and Reconvened for August 12, 2024
Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it intends to adjourn each of the special meeting of Churchill VII stockholders (the "Stockholder Special Meeting") and the meeting of Churchill VII warrant holders (the "Warrant Holder Meeting"), which are currently scheduled for July 25, 2024, to be held in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), and Churchill VII (the
- PR Newswire
Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment Scheduled for July 25, 2024
Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it has scheduled a special meeting of Churchill VII stockholders (the "Stockholder Special Meeting") to be held in connection with the proposed business combination (the "Business Combination") between CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill VII and a meeting of Ch
- PR Newswire
Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Warrant Holder Meeting to Approve Warrant Amendment Scheduled for May 21, 2024
Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it has scheduled a special meeting of Churchill VII stockholders and a meeting of Churchill VII warrant holders for May 21, 2024 in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill VII (the "Business Combination"). T
